Seeing Is Believing
Currently out of the existing stock ratings of Kerry Holford, 9 are a HOLD (64.29%), 5 are a BUY (35.71%).
Analyst Kerry Holford, currently employed at BERENBERG, carries an average stock price target met ratio of 41.67% that have a potential upside of 9.49% achieved within 109 days.
Kerry Holford’s has documented 38 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 14-Aug-2024.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 10/11/2021. The price target of $270 was fulfilled within 66 days with a profit of $43.22 (19.06%) receiving and performance score of 2.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$22.07
3 months 3 days ago
0/14 (0%)
$-16.41 (-42.65%)
Buy
$53
$14.18 (36.53%)
$48
3 months 9 days ago
2/4 (50%)
$14.79 (38.71%)
368
Hold
$44
$5.18 (13.34%)
$18.72
8 months 18 days ago
1/14 (7.14%)
$5.42 (14.05%)
107
Hold
$19.52
$-19.3 (-49.72%)
$18.9
1 years 1 months 27 days ago
0/3 (0%)
$-14.59 (-42.77%)
Hold
$19.58
$-22.45 (-53.41%)
$19.96
1 years 5 months 20 days ago
0/2 (0%)
$-16.05 (-45.05%)
Which stock is Kerry Holford is most bullish on?
What Year was the first public recommendation made by Kerry Holford?